Practice Management Tip of the Month: Communicating with Your Patients is Critical During COVID-19 {#sec1}
==================================================================================================

Your patients continue to be bombarded with information on COVID-19 daily, and many may still be confused about how to safely manage their allergic disease in face of the continually changing information. They will look to you for guidance on how to minimize risk, and determine which information sources are credible and which are suspect. Here are a few ideas:•Make sure all of your practice\'s COVID-19 precautions and requirements are prominently displayed on the homepage of your website, and communicated via text, email or phone call before the patient\'s appointment. This will help calm fears about the safety of visiting the office.•Continue utilizing telemedicine visits for appointments when appropriate. This helps reduce the number of people in the office and reduce the volume of PPE needed for your staff. Some patients may prefer telemedicine visits to in-person visits and will appreciate having this option.•Provide your patients with information from credible sources, such as the Centers for Disease Control and Prevention (CDC), World Health Organization (WHO) and AAAAI, and link to these resources from your practice website or provide any available handouts with the information.

Be sure to visit the AAAAI COVID-19 resources page for up-to-the-minute information, like our new patient handout on wearing a face covering or mask, which is available in English and Spanish.

The Practice Management Tip of the Month is a feature that appears in Practice Matters, the AAAAI\'s semimonthly newsletter with information and resources tailored for the practicing allergist. If you are an AAAAI member and have not been receiving Practice Matters, contact <practicematters@aaaai.org>.

Read This Featured Coding Question from Practice Matters {#sec2}
========================================================

**Question:** Our nurses now screen every patient coming into our office for an immunotherapy injection to assess for possible COVID-19 symptoms or exposure. We are also having them check each patient\'s temperature prior to giving the injection. This is above and beyond the usual screening and evaluation that would occur prior to an immunotherapy injection. If the questions and temperature check are both documented for each patient, would it be appropriate to bill each patient for CPT 99211 \[Office or other outpatient visit for the evaluation and management of an established patient, that may require the presence of a physician or other qualified healthcare professional. Usually, the presenting problem(s) are minimal. Typically, 5 minutes are spent performing or supervising these services\] along with the injection charge for the shot, adding a 25 modifier?

**Answer:** This service meets the definition of the 25 modifier with the "separate and distinct" from what is required for administering an allergy injection.

If you have a coding question of your own, send it to <coding@aaaai.org>. A coding question is also featured in every issue of Practice Matters.

Overcome Your Practice Challenges {#sec3}
=================================

The Practice Management Workshop is Going Virtual {#sec3.1}
-------------------------------------------------

COVID-19 has ushered in a whole new set of practice challenges in 2020. We\'ve heard numerous stories from members about financial struggles, lost job opportunities and difficulties setting up telemedicine services fast enough to meet demand.

That\'s why the 2020 AAAAI Practice Management Workshop has pivoted to focus on building virtual content to help you tackle the new challenges you\'re facing in your practice due to COVID-19. Over the course of the summer, we hosted free webinars for AAAAI members and their practice staff covering a variety of topics related to COVID-19. All of these summer webinars were recorded and will be available free of charge online.

The Virtual Practice Management Workshop won\'t be stopping there. We\'re hard at work putting together virtual sessions on some of our most requested topics originally scheduled for our live event this summer. These additional sessions will come with a fee and will be released in the fall. A final listing is still pending, but we plan to offer:•The FIT/NAIA learning track, to assist our newest members as they begin their careers in practice•Coding education from our coding expert Teresa Thompson, CPC, CCC, CMSCS•Education tailored for practice managers

Keep an eye on the AAAAI website for more details about our COVID-19 recordings and upcoming practice management webinars.

Recorded Webinars {#sec4}
=================

EIDL, PPP and Stimulus Payments: How Do I Keep it All Straight? {#sec4.1}
---------------------------------------------------------------

This session reviewed the variety of financial assistance programs available through the CARES Act for allergy/immunology practices and the requirements for each specific option, including appropriate expenditures and reporting requirements. A practicing allergist and practice manager also shared their experiences with the process and how they\'ve adapted practice protocols.

Job Prospects During the COVID-19 Pandemic: What Options Exist? {#sec4.2}
---------------------------------------------------------------

This session addressed alternative employment options during the COVID-19 pandemic for anyone experiencing employment changes such as reduced work hours, loss of income, or layoffs/furloughs due to the pandemic. Panelists reviewed options for private practice, academic practice, and non-traditional options such as consulting.

Academic Practice Management in the COVID-19 Pandemic {#sec4.3}
-----------------------------------------------------

Geared specifically for members in academic practice, this session discussed new challenges presented by the COVID-19 pandemic, including managing clinical trial patients, interviewing for FIT positions virtually, and workflow and process changes.

Telemedicine Strategies for COVID-19 and Beyond {#sec4.4}
-----------------------------------------------

The Centers for Medicare and Medicaid Services (CMS) and commercial payers have relaxed rules and requirements for telemedicine during the COVID-19 pandemic, but how long will these changes last? This webinar provided the most up-to-date information available on telemedicine regulations, rules, and coding and billing protocols. It also covered how the AAAAI has been advocating for the continuation of expanded telemedicine rules and how individual allergists can make an impact in their state.

Engineering Your Practice for the Continuing Crisis {#sec4.5}
---------------------------------------------------

As COVID-19 cases continue to expand across many areas of the country, practices are grappling with how to best meet the needs of patients, maintain staff safety, and keep the practice moving forward. This lively panel discussion reviewed key lessons learned during the COVID-19 pandemic to date and provided practical ideas that will help your practice meet the continuing challenges of the pandemic.

Your Guide to Using Telemedicine for Drug Allergy Assessments {#sec5}
=============================================================

Telemedicine is more important than ever now that practices must limit the number of people they see in their offices due to COVID-19. While this is necessary for the safety of your patients, your staff and yourself, you may be at a loss at how to complete certain assessments virtually. The AAAAI has put together two online courses on performing drug allergy assessments via telemedicine to help you expand your scope of practice. Both offer CME credit and are available free of charge.

**Drug Allergy Assessment Using Telemedicine and Electronic Consultations** with speaker Allison Ramsey, MD, FAAAAI

You will:•Get an outline on how telemedicine and e-consults can be used for drug allergy evaluations.•Learn how to identify patient characteristics that make direct challenges to penicillin and other medications an appropriate consideration.•Discover how to assess low risk drug allergy histories and select those for which an at-home reintroduction may be offered.

**Chemotherapy Hypersensitivity Reactions Assessment Using Telemedicine and Electronic Consultations** with speaker Aleena Banerji, MD, FAAAAI

You will:•Receive an overview of chemotherapy hypersensitivity reactions (HSR) assessments.•Learn about the critical role allergists play in evaluation and management of patients who have chemotherapy reactions.•Get suggestions on how you can work with local oncologists to help those looking to expand their scope of practice using telemedicine.•Learn about the key elements of conducting patient evaluations for chemotherapy and monoclonal antibody HSRs via telemedicine.

You can find both courses at the AAAAI Continuing Education Center at [education.aaaai.org](http://education.aaaai.org){#intref0020}.

2021 AAAAI Annual Meeting Will Be Entirely Virtual {#sec6}
==================================================

The AAAAI Board of Directors and the AAAAI Annual Meeting Program Committee (AMPC) have been monitoring the course of the COVID-19 pandemic and the unfortunate trends that heighten concerns over safety, the need for social distancing, and the financial/economic impact on allergy practice. After careful deliberation we have made the decision to change our 2021 Annual Meeting from an in-person event to an entirely virtual program featuring a mix of live streaming and recorded sessions. We felt it important to make this decision now in order to assure ample time to plan a stellar meeting in a fully virtual format. Although we are disappointed that we won\'t be able to see each other in San Diego February 26-March 1, 2021, our commitment to providing you with high quality, engaging, and state-of-the-art sessions to meet your CME/educational needs remains the same.

We will be working closely with our meeting faculty to develop optimal virtual presentation formats for all those sessions you look forward to every year: the keynote, plenaries, symposia, workshops, seminars, pro-con debates and more. We will showcase cutting-edge research, the best clinical science, and case reports in our Virtual Poster Hall and oral abstract sessions.

In addition, we plan to have:•A Virtual Exhibit Hall to allow you to keep up with the latest products and services available in our field.•Virtual AAAAI Foundation opportunities and events to recognize our Faculty Development Award recipients and support the AAAAI Foundation mission.

The AAAAI will provide you with updates as work progresses on our new virtual format. In the meantime, keep your calendars marked for the 2021 Virtual AAAAI Annual Meeting, February 26-March 1, that will focus on the clinical theme of: Incorporating New and Emerging Therapies Into Allergy/Immunology Practice and Research.Lay OrganizationsThe AAAAI places a high value on its relationships with patient advocacy organizations in support of our mutual concern for the needs of people with allergy, asthma and immunologic disease and their families. In particular, the AAAAI has an ongoing relationship with a group of organizations with whom we partner on various projects as needs and opportunities arise. We encourage you to visit these organizations\' websites for more information on their initiatives and missions.Allergy & Asthma Network[allergyasthmanetwork.org](http://allergyasthmanetwork.org){#intref0025}American Partnership for Eosinophilic Disorders (APFED)[apfed.org](http://apfed.org){#intref0030}Asthma & Allergy Foundation of America (AAFA)[aafa.org](http://aafa.org){#intref0035}Alaska Chapter: [aafaalaska.com](http://aafaalaska.com){#intref0040}California Chapter: [aafa-ca.com](http://aafa-ca.com){#intref0045}Greater Kansas City Chapter: [aafakc.org](http://aafakc.org){#intref0050}Maryland/Washington DC Chapter: [aafa-md.org](http://aafa-md.org){#intref0055}Michigan Chapter: [aafamich.org](http://aafamich.org){#intref0060}New England Chapter: [asthmaandallergies.org](http://asthmaandallergies.org){#intref0065}Texas Chapter: [aafatexas.org](http://aafatexas.org){#intref0070}St. Louis Chapter: [aafastl.org](http://aafastl.org){#intref0075}Campaign Urging Research for Eosinophilic Disease (CURED)[curedfoundation.org](http://curedfoundation.org){#intref0080}Food Allergy and Anaphylaxis Connection Team (FAACT)[foodallergyawareness.org](http://foodallergyawareness.org){#intref0085}Food Allergy Research & Education (FARE)[foodallergy.org](http://foodallergy.org){#intref0090}Immune Deficiency Foundation (IDF)[primaryimmune.org](http://primaryimmune.org){#intref0095}International FPIES Association[fpies.org](http://fpies.org){#intref0100}The Mastocytosis Society (TMS)[tmsforacure.org](http://tmsforacure.org){#intref0105}US Hereditary Angioedema Association (HAEA)[haea.org](http://haea.org){#intref0110}
